Tirzepatide is a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://robertwlun829939.blogrelation.com/47152346/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist